Peter Staib
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 40
- Acute Myeloid Leukemia Research 30
- Chronic Myeloid Leukemia Treatments 13
- Epidemiology 37
- Fungal Infections and Studies 23
- Nail Diseases and Treatments 12
- Co-authors
- Joachim Morschhäuser (24 shared papers)Wolfgang Kern (9 shared papers)Torsten Haferlach (10 shared papers)Michel Monod (16 shared papers)Susanne Schnittger (7 shared papers)Hubert Serve (8 shared papers)Thomas Büchner (10 shared papers)Claudia Schoch (11 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Blood (14 papers)Annals of Oncology (7 papers)International Journal of Cosmetic Science (5 papers)Infection and Immunity (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Peter Staib
137 papers receiving 6.0k citations
Peter Staib's Hit Papers
Peers
Comparison fields: 5 of 131
- Hematology 2.2k
- Genetics 1.3k
- Infectious Diseases 1.1k
- Epidemiology 1.2k
- Oncology 887
Countries citing papers authored by Peter Staib
This map shows the geographic impact of Peter Staib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staib more than expected).
Fields of papers citing papers by Peter Staib
This network shows the impact of papers produced by Peter Staib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staib. The network helps show where Peter Staib may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Staib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease Hit paper breakdown → | 2002 | 784 |
| 2 | 2011 | 277 | |
| 3 | 2008 | 239 | |
| 4 | 2003 | 222 | |
| 5 | 2006 | 209 | |
| 6 | 2012 | 185 | |
| 7 | 2012 | 161 | |
| 8 | 2005 | 159 | |
| 9 | 2022 | 146 | |
| 10 | 2000 | 136 | |
| 11 | 1999 | 133 | |
| 12 | 2001 | 132 | |
| 13 | 2006 | 124 | |
| 14 | 2003 | 121 | |
| 15 | 1999 | 112 | |
| 16 | 1999 | 106 | |
| 17 | 2013 | 104 | |
| 18 | 2002 | 100 | |
| 19 | 2010 | 96 | |
| 20 | 2021 | 88 |
About Peter Staib
Peter Staib is a scholar working on Hematology, Epidemiology, Infectious Diseases, Molecular Biology and Genetics, having authored 142 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Antifungal resistance and susceptibility (28 papers), Fungal Infections and Studies (23 papers), Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers), Nail Diseases and Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Acute Lymphoblastic Leukemia research (10 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (1.3k citations), Infectious Diseases (1.1k citations), Epidemiology (1.2k citations) and Oncology (887 citations). Peter Staib has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Joachim Morschhäuser, Wolfgang Kern, Torsten Haferlach, Michel Monod, Susanne Schnittger, Hubert Serve, Thomas Büchner, Claudia Schoch, Wolfgang Hiddemann and Helmut Löffler. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, International Journal of Cosmetic Science and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.